Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.
Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa [listed at the end of the article]. Domènech E, et al. Among authors: dignass a. J Crohns Colitis. 2018 May 25;12(6):687-694. doi: 10.1093/ecco-jcc/jjy023. J Crohns Colitis. 2018. PMID: 29490024 Clinical Trial.
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.
Kruis W, Dignass A, Steinhagen-Thiessen E, Morgenstern J, Mössner J, Schreiber S, Vecchi M, Malesci A, Reinshagen M, Löfberg R. Kruis W, et al. Among authors: dignass a. World J Gastroenterol. 2005 Nov 28;11(44):7001-6. doi: 10.3748/wjg.v11.i44.7001. World J Gastroenterol. 2005. PMID: 16437606 Free PMC article. Clinical Trial.
N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis.
O'Connor M, Bager P, Duncan J, Gaarenstroom J, Younge L, Détré P, Bredin F, Dibley L, Dignass A, Gallego Barrero M, Greveson K, Hamzawi M, Ipenburg N, Keegan D, Martinato M, Murciano Gonzalo F, Pino Donnay S, Price T, Ramirez Morros A, Verwey M, White L, van de Woude CJ. O'Connor M, et al. Among authors: dignass a. J Crohns Colitis. 2013 Oct;7(9):744-64. doi: 10.1016/j.crohns.2013.06.004. Epub 2013 Jul 5. J Crohns Colitis. 2013. PMID: 23831217 No abstract available.
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, Befrits R, Midhagen G, Rademaker J, Foldager M. Marteau P, et al. Among authors: dignass a. Gut. 2005 Jul;54(7):960-5. doi: 10.1136/gut.2004.060103. Gut. 2005. PMID: 15951542 Free PMC article. Clinical Trial.
322 results